Martin Bhatt
MD
Medical Oncologist
👥Biography 个人简介
Martin Bhatt contributed to clinical research on brentuximab vedotin-based frontline therapy for advanced Hodgkin lymphoma through the ECHELON-1 trial. His research helped establish A+AVD as an alternative to ABVD for advanced-stage Hodgkin lymphoma based on improved modified PFS. He has studied peripheral neuropathy management with brentuximab vedotin and G-CSF prophylaxis strategies. His translational work bridges CD30 antibody-drug conjugate biology with clinical practice in Hodgkin lymphoma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Martin Bhatt 的研究动态
Follow Martin Bhatt's research updates
留下邮箱，当我们发布与 Martin Bhatt（Seattle Cancer Care Alliance）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment